Australia
Rouse and IPH, two businesses that have made a flurry of acquisitions, share the lessons learned from their journeys
External investor-controlled IP firms have both downsides and upsides, so they don’t deserve all the flak they get
Andrew Blattman, CEO of IPH, tells Managing IP what’s next for the group in Canada and how it navigates issues such as conflicts and cost efficiency
John O’Shea has left IPH after six years as the company seeks to streamline its Asia-Pacific and Canada businesses
Sponsored
Sponsored
-
Sponsored by AJ ParkKieran O’Connell and Stephanie Randle of AJ Park discuss the importance of deciding on the applicant of a trademark in light of two decisions by the Intellectual Property Office of New Zealand -
Sponsored by FB RiceStefania Sassnink and Paul Whenman of FB Rice provide a guide to when third parties can be held responsible for patent infringement on the basis of supplying a product
-
Sponsored by FB RiceJacqueline Warner and Marcus Caulfield of FB Rice explain the significance of common general knowledge (CGK) in the patentability of inventions in Australia and the evidentiary processes that are adopted as a result
-
Sponsored by FB RicePaul Whenman of FB Rice reviews recent cases concerning patent term extension (PTE) for human pharmaceutical products in Australia
-
Sponsored by FB RiceLee Miles of FB Rice discusses Australia’s patent box scheme which is set to introduce the agricultural and low emissions technology sectors
-
Sponsored by FB RiceCory Smith and Kate Mahady of FB Rice explain how Australian companies can use the R&D Tax Incentive to offset the costs of their IP
